A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
NCT05820672 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2026-04-21
Summary
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
Conditions
- Growth Hormone Deficiency
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Ascendis Pharma Endocrinology Division A/S
lead INDUSTRY
Principal Investigators
-
Medical Director, MD · Ascendis Pharma A/S
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-20
- Primary Completion
- 2033-03-31
- Completion
- 2033-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
NCT04615273 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
NCT05690386 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information
NCT05718570 ·Status: ENROLLING_BY_INVITATION
-
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
NCT00570011 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT02908958 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
NCT07221851 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
NCT00174278 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
NCT01604161 ·Status: COMPLETED
-
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
NCT00171730 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
NCT02382939 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
NCT01995734 ·Status: APPROVED_FOR_MARKETING
-
A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency
NCT02311894 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
NCT05171855 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
NCT02229851 ·Status: COMPLETED ·Phase: PHASE3
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
NCT03305016 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Long-term Somatropin Treatment in Adults
NCT01543880 ·Status: COMPLETED
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
NCT00455884 ·Status: COMPLETED
-
Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed
NCT06109935 ·Status: ENROLLING_BY_INVITATION
-
Treatment of Adults With Growth Hormone Deficiency
NCT00596037 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)
NCT05796440 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2